講師資料
Talks：
The Prevalence, screen, diagnosis and treatment of obstructive sleep apnea in Hypertension population
Name：
黃群耀(Chun-Yao Huang)
Position：
1.Director, Department of Internal Medicine, Taipei Medical University Hospital, Taiwan
2.Director, Division of Cardiology, Taipei Medical University hospital, Taiwan
Affiliation：
1.Division of Cardiology, Department of Internal Medicine, Taipei Medical University hospital, Taiwan
2.Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan
3.Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Email：
Photo：
Research Interests：
Vascular Biology, Lipidology, Cardiac Pharmacology, Big data, Wearable device
Selected Publications：
Totally 100 SCI original articles
Articles last year:
1. Transferring Plasmon Effect on a Biological System: Expression of Biological Polymers in Chronic Rejection and Inflammatory Rat Model DOI: https://doi.org/10.3390/polym13111827. May 31,2021.
2. A Novel Relative High-Density Lipoprotein Index to Predict the Structural Changes in High-Density Lipoprotein and Its Ability to Inhibit Endothelial–Mesenchymal Transition DOI: 10.3390/ijms22105210.May 14,2021.
3. Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study. DOI: 10.1371/journal.pone.0249940. Apr 28,2021.
4. (SCI) Patient satisfaction with dabigatrean and warfarin for stroke prevention in atrial fibrillation: Taiwan PASSION study. DOI: 10.1097/JCMA.0000000000000496. Apr 01,2021
5. (SCI) Circulating level of microRNA-142-5p is a potential biomarker for predicting in-stent restenosis: a case–control study. DOI: 10.1186/s12872-021-01893-y. Feb 08,2021
6. (SCI) The effect of de-escalation of P2Y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study DOI: 0.1371/journal.pone.0246029.Jan 25,2021
Abstract：
With the progress of the civilized world, the prevalence of hypertension is increasing day by day, and hypertension in Taiwan is also listed as one of the top ten causes of death of the year. Sleep breathing arrest syndrome is a common disease in the civilized world, but also because of the lack of medical advocacy, knowledge promotion, and simple detection methods, although sleep breathing is a very important disease, it is the most easily ignored risk factor for hypertension. The disease can only be screened out through the patient's disease awareness and the vigilance of the clinician, with appropriate measurement tables and screening tools. At present, the tools for the treatment of respiratory arrest syndrome have gradually matured and have certain clinical efficacy, so it is time to face up to and promote the treatment of sleep apnea syndrome in the hypertensive population.